{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T12:22:19Z","timestamp":1792844539224,"version":"4.5.0"},"reference-count":142,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T00:00:00Z","timestamp":1754870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T00:00:00Z","timestamp":1754870400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100018537","name":"National Science and Technology Major Project","doi-asserted-by":"publisher","award":["2024ZD0529200"],"award-info":[{"award-number":["2024ZD0529200"]}],"id":[{"id":"10.13039\/501100018537","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82271278"],"award-info":[{"award-number":["82271278"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Outstanding Youth Project of Natural Science Foundation of Hubei province and 2023 Science and Technology Development Project Approved by Chinese Association of Rehabilitation Medicine","award":["2023020601012303"],"award-info":[{"award-number":["2023020601012303"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1007\/s00415-025-13288-6","type":"journal-article","created":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T17:00:50Z","timestamp":1754931650000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Restless legs syndrome in Parkinson\u2019s disease: epidemiology, pathogenetic overlaps, and clinical management"],"prefix":"10.1007","volume":"272","author":[{"given":"Zhixin","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shurui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanshu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinwei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guiying","family":"Kuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaqing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danfang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1371-0522","authenticated-orcid":false,"given":"Nian","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,11]]},"reference":[{"key":"13288_CR1","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S0140-6736(23)01478-2","volume":"403","author":"HR Morris","year":"2024","unstructured":"Morris HR, Spillantini MG, Sue CM, Williams-Gray CH (2024) The pathogenesis of Parkinson\u2019s disease. Lancet 403:293\u2013304. https:\/\/doi.org\/10.1016\/S0140-6736(23)01478-2","journal-title":"Lancet"},{"issue":"Suppl 18","key":"13288_CR2","doi-asserted-by":"publisher","first-page":"S424","DOI":"10.1002\/mds.21600","volume":"22","author":"A Iranzo","year":"2007","unstructured":"Iranzo A, Comella CL, Santamaria J, Oertel W (2007) Restless legs syndrome in Parkinson\u2019s disease and other neurodegenerative diseases of the central nervous system. Mov Disord 22(Suppl 18):S424-430. https:\/\/doi.org\/10.1002\/mds.21600","journal-title":"Mov Disord"},{"key":"13288_CR3","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/S1474-4422(24)00170-4","volume":"23","author":"A Iranzo","year":"2024","unstructured":"Iranzo A, Cochen De Cock V, Fantini ML, P\u00e9rez-Carbonell L, Trotti LM (2024) Sleep and sleep disorders in people with Parkinson\u2019s disease. Lancet Neurol 23:925\u2013937. https:\/\/doi.org\/10.1016\/S1474-4422(24)00170-4","journal-title":"Lancet Neurol"},{"key":"13288_CR4","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/S1474-4422(05)70139-3","volume":"4","author":"C Trenkwalder","year":"2005","unstructured":"Trenkwalder C, Paulus W, Walters AS (2005) The restless legs syndrome. Lancet Neurol 4:465\u2013475. https:\/\/doi.org\/10.1016\/S1474-4422(05)70139-3","journal-title":"Lancet Neurol"},{"key":"13288_CR5","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1097\/00004691-200103000-00004","volume":"18","author":"RP Allen","year":"2001","unstructured":"Allen RP, Earley CJ (2001) Restless legs syndrome: a review of clinical and pathophysiologic features. J Clin Neurophysiol 18:128\u2013147. https:\/\/doi.org\/10.1097\/00004691-200103000-00004","journal-title":"J Clin Neurophysiol"},{"key":"13288_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2018.00551","volume":"9","author":"L Ferini-Strambi","year":"2018","unstructured":"Ferini-Strambi L, Carli G, Casoni F, Galbiati A (2018) Restless legs syndrome and Parkinson disease: a causal relationship between the two disorders? Front Neurol 9:551. https:\/\/doi.org\/10.3389\/fneur.2018.00551","journal-title":"Front Neurol"},{"key":"13288_CR7","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/2763808","volume":"2020","author":"H Ghasemi","year":"2020","unstructured":"Ghasemi H, Khaledi-Paveh B, Abdi A, Jalali R, Salari N, Vaisi-Raygani A, Mohammadi M (2020) The prevalence of restless legs syndrome in patients with migraine: a systematic review and meta-analysis. Pain Res Manag 2020:2763808. https:\/\/doi.org\/10.1155\/2020\/2763808","journal-title":"Pain Res Manag"},{"key":"13288_CR8","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1111\/ene.14840","volume":"28","author":"FJ Jim\u00e9nez-Jim\u00e9nez","year":"2021","unstructured":"Jim\u00e9nez-Jim\u00e9nez FJ, Alonso-Navarro H, Garc\u00eda-Mart\u00edn E, Ag\u00fandez JAG (2021) Association between restless legs syndrome and peripheral neuropathy: a systematic review and meta-analysis. Eur J Neurol 28:2423\u20132442. https:\/\/doi.org\/10.1111\/ene.14840","journal-title":"Eur J Neurol"},{"key":"13288_CR9","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.sleep.2010.07.007","volume":"11","author":"CJ Earley","year":"2010","unstructured":"Earley CJ, Silber MH (2010) Restless legs syndrome: understanding its consequences and the need for better treatment. Sleep Med 11:807\u2013815. https:\/\/doi.org\/10.1016\/j.sleep.2010.07.007","journal-title":"Sleep Med"},{"key":"13288_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2022.101357","volume":"46","author":"P Ning","year":"2022","unstructured":"Ning P, Mu X, Yang X, Li T, Xu Y (2022) Prevalence of restless legs syndrome in people with diabetes mellitus: a pooling analysis of observational studies. EClinMed 46:101357. https:\/\/doi.org\/10.1016\/j.eclinm.2022.101357","journal-title":"EClinMed"},{"key":"13288_CR11","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1093\/ndt\/gfz097","volume":"35","author":"C-W Huang","year":"2020","unstructured":"Huang C-W, Lee M-J, Wang L-J, Lee P-T, Tu Y-K, Hsu C-W, Lin P-Y (2020) Comparative efficacy and acceptability of treatments for restless legs syndrome in end-stage renal disease: a systematic review and network meta-analysis. Nephrol Dial Transplant 35:1609\u20131618. https:\/\/doi.org\/10.1093\/ndt\/gfz097","journal-title":"Nephrol Dial Transplant"},{"key":"13288_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.smrv.2021.101463","volume":"58","author":"R Gupta","year":"2021","unstructured":"Gupta R, Gupta R, Kumar N, Rawat VS, Ulfberg J, Allen RP (2021) Restless legs syndrome among subjects having chronic liver disease: a systematic review and meta-analysis. Sleep Med Rev 58:101463. https:\/\/doi.org\/10.1016\/j.smrv.2021.101463","journal-title":"Sleep Med Rev"},{"key":"13288_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12883-019-1585-y","volume":"20","author":"X Zhang","year":"2020","unstructured":"Zhang X, Lang Y, Sun L, Zhang W, Lin W, Cui L (2020) Clinical characteristics and prognostic analysis of anti-gamma-aminobutyric acid-B (GABA-B) receptor encephalitis in northeast China. BMC Neurol 20:1. https:\/\/doi.org\/10.1186\/s12883-019-1585-y","journal-title":"BMC Neurol"},{"key":"13288_CR14","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/zsw065","volume":"40","author":"S Szatmari","year":"2017","unstructured":"Szatmari S, Bereczki D, Fornadi K, Kalantar-Zadeh K, Kovesdy CP, Molnar MZ (2017) Association of restless legs syndrome with incident Parkinson\u2019s disease. Sleep 40:zsw065. https:\/\/doi.org\/10.1093\/sleep\/zsw065","journal-title":"Sleep"},{"key":"13288_CR15","doi-asserted-by":"publisher","first-page":"VII33","DOI":"10.1007\/s00415-006-7008-1","volume":"253 Suppl 7","author":"E-K Tan","year":"2006","unstructured":"Tan E-K (2006) Restless legs syndrome and Parkinson\u2019s disease: is there an etiologic link? J Neurol 253 Suppl 7:VII33\u2013VII37. https:\/\/doi.org\/10.1007\/s00415-006-7008-1","journal-title":"J Neurol"},{"key":"13288_CR16","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1002\/mds.23430","volume":"26","author":"RP Allen","year":"2011","unstructured":"Allen RP, Bharmal M, Calloway M (2011) Prevalence and disease burden of primary restless legs syndrome: results of a general population survey in the United States. Mov Disord 26:114\u2013120. https:\/\/doi.org\/10.1002\/mds.23430","journal-title":"Mov Disord"},{"key":"13288_CR17","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s11940-015-0390-1","volume":"18","author":"F Rinaldi","year":"2016","unstructured":"Rinaldi F, Galbiati A, Marelli S, Ferini Strambi L, Zucconi M (2016) Treatment options in intractable restless legs syndrome\/willis-ekbom disease (RLS\/WED). Curr Treat Options Neurol 18:7. https:\/\/doi.org\/10.1007\/s11940-015-0390-1","journal-title":"Curr Treat Options Neurol"},{"key":"13288_CR18","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/490938","volume":"2015","author":"K Suzuki","year":"2015","unstructured":"Suzuki K, Miyamoto M, Miyamoto T, Hirata K (2015) Restless legs syndrome and leg motor restlessness in Parkinson\u2019s disease. Parkinsons Dis 2015:490938. https:\/\/doi.org\/10.1155\/2015\/490938","journal-title":"Parkinsons Dis"},{"key":"13288_CR19","doi-asserted-by":"publisher","DOI":"10.1111\/jsr.13783","volume":"32","author":"A Brostr\u00f6m","year":"2023","unstructured":"Brostr\u00f6m A, Alimoradi Z, Lind J, Ulander M, Lundin F, Pakpour A (2023) Worldwide estimation of restless legs syndrome: a systematic review and meta-analysis of prevalence in the general adult population. J Sleep Res 32:e13783. https:\/\/doi.org\/10.1111\/jsr.13783","journal-title":"J Sleep Res"},{"issue":"Suppl 1","key":"13288_CR20","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1016\/S1353-8020(13)70004-X","volume":"20","author":"RM Rijsman","year":"2014","unstructured":"Rijsman RM, Schoolderman LF, Rundervoort RS, Louter M (2014) Restless legs syndrome in Parkinson\u2019s disease. Parkinsonism Relat Disord 20(Suppl 1):S5-9. https:\/\/doi.org\/10.1016\/S1353-8020(13)70004-X","journal-title":"Parkinsonism Relat Disord"},{"key":"13288_CR21","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1212\/WNL.0000000000007500","volume":"92","author":"H Alonso-Navarro","year":"2019","unstructured":"Alonso-Navarro H, Garc\u00eda-Mart\u00edn E, Ag\u00fandez JAG, Jim\u00e9nez-Jim\u00e9nez FJ (2019) Association between restless legs syndrome and other movement disorders. Neurology 92:948\u2013964. https:\/\/doi.org\/10.1212\/WNL.0000000000007500","journal-title":"Neurology"},{"key":"13288_CR22","doi-asserted-by":"publisher","first-page":"405","DOI":"10.5665\/sleep.5452","volume":"39","author":"M Moccia","year":"2016","unstructured":"Moccia M, Erro R, Picillo M, Santangelo G, Spina E, Allocca R, Longo K, Amboni M, Palladino R, Assante R, Pappat\u00e0 S, Pellecchia MT, Barone P, Vitale C (2016) A four-year longitudinal study on restless legs syndrome in Parkinson disease. Sleep 39:405\u2013412. https:\/\/doi.org\/10.5665\/sleep.5452","journal-title":"Sleep"},{"key":"13288_CR23","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1212\/wnl.37.3.477","volume":"37","author":"AE Lang","year":"1987","unstructured":"Lang AE, Johnson K (1987) Akathisia in idiopathic Parkinson\u2019s disease. Neurology 37:477\u2013481. https:\/\/doi.org\/10.1212\/wnl.37.3.477","journal-title":"Neurology"},{"key":"13288_CR24","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/mds.10307","volume":"18","author":"PR Krishnan","year":"2003","unstructured":"Krishnan PR, Bhatia M, Behari M (2003) Restless legs syndrome in Parkinson\u2019s disease: a case-controlled study. Mov Disord 18:181\u2013185. https:\/\/doi.org\/10.1002\/mds.10307","journal-title":"Mov Disord"},{"key":"13288_CR25","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1001\/archneur.59.3.421","volume":"59","author":"WG Ondo","year":"2002","unstructured":"Ondo WG, Vuong KD, Jankovic J (2002) Exploring the relationship between Parkinson disease and restless legs syndrome. Arch Neurol 59:421\u2013424. https:\/\/doi.org\/10.1001\/archneur.59.3.421","journal-title":"Arch Neurol"},{"key":"13288_CR26","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1093\/sleep\/31.2.219","volume":"31","author":"YW Cho","year":"2008","unstructured":"Cho YW, Shin WC, Yun CH, Hong SB, Kim JH, Allen RP, Earley CJ (2008) Epidemiology of restless legs syndrome in Korean adults. Sleep 31:219\u2013223. https:\/\/doi.org\/10.1093\/sleep\/31.2.219","journal-title":"Sleep"},{"key":"13288_CR27","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1002\/mds.22410","volume":"24","author":"JE Lee","year":"2009","unstructured":"Lee JE, Shin H-W, Kim KS, Sohn YH (2009) Factors contributing to the development of restless legs syndrome in patients with Parkinson disease. Mov Disord 24:579\u2013582. https:\/\/doi.org\/10.1002\/mds.22410","journal-title":"Mov Disord"},{"key":"13288_CR28","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/s0022-510x(02)00020-5","volume":"196","author":"EK Tan","year":"2002","unstructured":"Tan EK, Lum SY, Wong MC (2002) Restless legs syndrome in Parkinson\u2019s disease. J Neurol Sci 196:33\u201336. https:\/\/doi.org\/10.1016\/s0022-510x(02)00020-5","journal-title":"J Neurol Sci"},{"key":"13288_CR29","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1002\/mds.22694","volume":"24","author":"CM Peralta","year":"2009","unstructured":"Peralta CM, Frauscher B, Seppi K, Wolf E, Wenning GK, H\u00f6gl B, Poewe W (2009) Restless legs syndrome in Parkinson\u2019s disease. Mov Disord 24:2076\u20132080. https:\/\/doi.org\/10.1002\/mds.22694","journal-title":"Mov Disord"},{"key":"13288_CR30","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1002\/mds.21624","volume":"22","author":"JC G\u00f3mez-Esteban","year":"2007","unstructured":"G\u00f3mez-Esteban JC, Zarranz JJ, Tijero B, Velasco F, Barcena J, Rouco I, Lezcano E, Lachen MC, Jauregui A, Ugarte A (2007) Restless legs syndrome in Parkinson\u2019s disease. Mov Disord 22:1912\u20131916. https:\/\/doi.org\/10.1002\/mds.21624","journal-title":"Mov Disord"},{"key":"13288_CR31","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jns.2003.08.010","volume":"217","author":"P Braga-Neto","year":"2004","unstructured":"Braga-Neto P, da Silva-J\u00fanior FP, Sueli Monte F, de Bruin PFC, de Bruin VMS (2004) Snoring and excessive daytime sleepiness in Parkinson\u2019s disease. J Neurol Sci 217:41\u201345. https:\/\/doi.org\/10.1016\/j.jns.2003.08.010","journal-title":"J Neurol Sci"},{"key":"13288_CR32","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1002\/mds.23241","volume":"25","author":"D Verbaan","year":"2010","unstructured":"Verbaan D, van Rooden SM, van Hilten JJ, Rijsman RM (2010) Prevalence and clinical profile of restless legs syndrome in Parkinson\u2019s disease. Mov Disord 25:2142\u20132147. https:\/\/doi.org\/10.1002\/mds.23241","journal-title":"Mov Disord"},{"key":"13288_CR33","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1212\/WNL.0b013e31823a0cc8","volume":"77","author":"MD Gjerstad","year":"2011","unstructured":"Gjerstad MD, Tysnes OB, Larsen JP (2011) Increased risk of leg motor restlessness but not RLS in early Parkinson disease. Neurology 77:1941\u20131946. https:\/\/doi.org\/10.1212\/WNL.0b013e31823a0cc8","journal-title":"Neurology"},{"key":"13288_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2012.03.022","author":"K Suzuki","year":"2012","unstructured":"Suzuki K, Miyamoto M, Miyamoto T, Tatsumoto M, Watanabe Y, Suzuki S, Iwanami M, Sada T, Kadowaki T, Numao A, Trenkwalder C (2012) Nocturnal disturbances and restlessness in Parkinson\u2019s disease: using the Japanese version of the Parkinson\u2019s disease sleep scale-2. J Neurol Sci. https:\/\/doi.org\/10.1016\/j.jns.2012.03.022","journal-title":"J Neurol Sci"},{"key":"13288_CR35","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.jns.2013.01.039","volume":"327","author":"AQ Rana","year":"2013","unstructured":"Rana AQ, Siddiqui I, Mosabbir A, Athar A, Syed O, Jesudasan M, Hafez K (2013) Association of pain, Parkinson\u2019s disease, and restless legs syndrome. J Neurol Sci 327:32\u201334. https:\/\/doi.org\/10.1016\/j.jns.2013.01.039","journal-title":"J Neurol Sci"},{"key":"13288_CR36","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/ane.12307","volume":"131","author":"S-M Fereshtehnejad","year":"2015","unstructured":"Fereshtehnejad S-M, Shafieesabet M, Shahidi GA, Delbari A, L\u00f6kk J (2015) Restless legs syndrome in patients with Parkinson\u2019s disease: a comparative study on prevalence, clinical characteristics, quality of life and nutritional status. Acta Neurol Scand 131:211\u2013218. https:\/\/doi.org\/10.1111\/ane.12307","journal-title":"Acta Neurol Scand"},{"key":"13288_CR37","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.sleep.2017.11.1146","volume":"43","author":"X Yang","year":"2018","unstructured":"Yang X, Liu B, Shen H, Li S, Zhao Q, An R, Hu F, Ren H, Xu Y, Xu Z (2018) Prevalence of restless legs syndrome in Parkinson\u2019s disease: a systematic review and meta-analysis of observational studies. Sleep Med 43:40\u201346. https:\/\/doi.org\/10.1016\/j.sleep.2017.11.1146","journal-title":"Sleep Med"},{"key":"13288_CR38","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000035551","volume":"102","author":"J-M Kim","year":"2023","unstructured":"Kim J-M, Choi S-M, Cho SH, Kim BC (2023) Restless legs syndrome affects sleep in de novo Parkinson\u2019s disease patients. Medicine (Baltimore) 102:e35551. https:\/\/doi.org\/10.1097\/MD.0000000000035551","journal-title":"Medicine (Baltimore)"},{"key":"13288_CR39","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.3233\/JPD-213100","volume":"12","author":"DL Bliwise","year":"2022","unstructured":"Bliwise DL, Karroum EG, Greer SA, Factor SA, Trotti LM (2022) Restless legs symptoms and periodic leg movements in sleep among patients with Parkinson\u2019s disease. J Parkinsons Dis 12:1339\u20131344. https:\/\/doi.org\/10.3233\/JPD-213100","journal-title":"J Parkinsons Dis"},{"key":"13288_CR40","doi-asserted-by":"publisher","DOI":"10.3390\/jpm13060915","volume":"13","author":"\u015e Diaconu","year":"2023","unstructured":"Diaconu \u015e, Irincu L, Ungureanu L, Ciopleia\u0219 B, \u021a\u00een\u021b D, Falup-Pecurariu C (2023) Restless legs syndrome in Parkinson\u2019s disease. J Pers Med 13:915. https:\/\/doi.org\/10.3390\/jpm13060915","journal-title":"J Pers Med"},{"key":"13288_CR41","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.sleep.2024.07.015","volume":"121","author":"G Maggi","year":"2024","unstructured":"Maggi G, Barone A, Mastromarino C, Santangelo G, Vitale C (2024) Prevalence and clinical profile of patients with restless legs syndrome in Parkinson\u2019s disease: a meta-analysis. Sleep Med 121:275\u2013286. https:\/\/doi.org\/10.1016\/j.sleep.2024.07.015","journal-title":"Sleep Med"},{"key":"13288_CR42","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j104","volume":"356","author":"D Garcia-Borreguero","year":"2017","unstructured":"Garcia-Borreguero D, Cano-Pumarega I (2017) New concepts in the management of restless legs syndrome. BMJ 356:j104. https:\/\/doi.org\/10.1136\/bmj.j104","journal-title":"BMJ"},{"key":"13288_CR43","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.jns.2015.07.008","volume":"357","author":"X-Y Zhu","year":"2015","unstructured":"Zhu X-Y, Liu Y, Zhang X-J, Yang W-H, Feng Y, Ondo WG, Tan E-K, Wu Y-C (2015) Clinical characteristics of leg restlessness in Parkinson\u2019s disease compared with idiopathic restless legs syndrome. J Neurol Sci 357:109\u2013114. https:\/\/doi.org\/10.1016\/j.jns.2015.07.008","journal-title":"J Neurol Sci"},{"issue":"Suppl 3","key":"13288_CR44","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.1212\/wnl.61.6_suppl_3.s49","volume":"61","author":"D Garcia-Borreguero","year":"2003","unstructured":"Garcia-Borreguero D, Odin P, Serrano C (2003) Restless legs syndrome and PD: a review of the evidence for a possible association. Neurology 61(Suppl 3):S49-55. https:\/\/doi.org\/10.1212\/wnl.61.6_suppl_3.s49","journal-title":"Neurology"},{"key":"13288_CR45","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.smrv.2006.01.001","volume":"10","author":"D Garcia-Borreguero","year":"2006","unstructured":"Garcia-Borreguero D, Egatz R, Winkelmann J, Berger K (2006) Epidemiology of restless legs syndrome: the current status. Sleep Med Rev 10:153\u2013167. https:\/\/doi.org\/10.1016\/j.smrv.2006.01.001","journal-title":"Sleep Med Rev"},{"key":"13288_CR46","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.jns.2007.09.033","volume":"266","author":"H-V Loo","year":"2008","unstructured":"Loo H-V, Tan E-K (2008) Case-control study of restless legs syndrome and quality of sleep in Parkinson\u2019s disease. J Neurol Sci 266:145\u2013149. https:\/\/doi.org\/10.1016\/j.jns.2007.09.033","journal-title":"J Neurol Sci"},{"key":"13288_CR47","doi-asserted-by":"publisher","first-page":"321","DOI":"10.3988\/jcn.2019.15.3.321","volume":"15","author":"S You","year":"2019","unstructured":"You S, Jeon SM, Do SY, Cho YW (2019) Restless legs syndrome in Parkinson\u2019s disease patients: clinical features including motor and nonmotor symptoms. J Clin Neurol 15:321\u2013327. https:\/\/doi.org\/10.3988\/jcn.2019.15.3.321","journal-title":"J Clin Neurol"},{"issue":"Suppl 18","key":"13288_CR48","doi-asserted-by":"publisher","first-page":"S476","DOI":"10.1002\/mds.21610","volume":"22","author":"D Garc\u00eda-Borreguero","year":"2007","unstructured":"Garc\u00eda-Borreguero D, Allen RP, Benes H, Earley C, Happe S, H\u00f6gl B, Kohnen R, Paulus W, Rye D, Winkelmann J (2007) Augmentation as a treatment complication of restless legs syndrome: Concept and management. Mov Disord 22(Suppl 18):S476-484. https:\/\/doi.org\/10.1002\/mds.21610","journal-title":"Mov Disord"},{"key":"13288_CR49","doi-asserted-by":"publisher","first-page":"526","DOI":"10.3109\/00207454.2014.987771","volume":"125","author":"EM Dragan","year":"2015","unstructured":"Dragan EM, Chen Z, Ondo WG (2015) Does idiopathic restless legs syndrome delay onset and reduce severity of Parkinson\u2019s disease: a pilot study. Int J Neurosci 125:526\u2013530. https:\/\/doi.org\/10.3109\/00207454.2014.987771","journal-title":"Int J Neurosci"},{"key":"13288_CR50","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/j.parkreldis.2013.06.018","volume":"19","author":"MK Scullin","year":"2013","unstructured":"Scullin MK, Sollinger AB, Land J, Wood-Siverio C, Zanders L, Lee R, Freeman A, Goldstein FC, Bliwise DL, Factor SA (2013) Sleep and impulsivity in Parkinson\u2019s disease. Parkinsonism Relat Disord 19:991\u2013994. https:\/\/doi.org\/10.1016\/j.parkreldis.2013.06.018","journal-title":"Parkinsonism Relat Disord"},{"key":"13288_CR51","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.sleep.2018.02.004","volume":"48","author":"A Marques","year":"2018","unstructured":"Marques A, Figorilli M, Pereira B, Derost P, Debilly B, Beudin P, Vidal T, Durif F, Fantini ML (2018) Impulse control disorders in Parkinson\u2019s disease patients with RLS: a cross sectional-study. Sleep Med 48:148\u2013154. https:\/\/doi.org\/10.1016\/j.sleep.2018.02.004","journal-title":"Sleep Med"},{"key":"13288_CR52","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s11065-020-09473-1","volume":"31","author":"G Maggi","year":"2021","unstructured":"Maggi G, Trojano L, Barone P, Santangelo G (2021) Sleep disorders and cognitive dysfunctions in Parkinson\u2019s disease: a meta-analytic study. Neuropsychol Rev 31:643\u2013682. https:\/\/doi.org\/10.1007\/s11065-020-09473-1","journal-title":"Neuropsychol Rev"},{"key":"13288_CR53","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.smrv.2011.09.003","volume":"16","author":"LB Weinstock","year":"2012","unstructured":"Weinstock LB, Walters AS, Paueksakon P (2012) Restless legs syndrome\u2013theoretical roles of inflammatory and immune mechanisms. Sleep Med Rev 16:341\u2013354. https:\/\/doi.org\/10.1016\/j.smrv.2011.09.003","journal-title":"Sleep Med Rev"},{"key":"13288_CR54","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1176\/appi.psy.51.6.474","volume":"51","author":"M Menza","year":"2010","unstructured":"Menza M, Dobkin RD, Marin H, Mark MH, Gara M, Bienfait K, Dicke A, Kusnekov A (2010) The role of inflammatory cytokines in cognition and other non-motor symptoms of Parkinson\u2019s disease. Psychosomatics 51:474\u2013479. https:\/\/doi.org\/10.1176\/appi.psy.51.6.474","journal-title":"Psychosomatics"},{"key":"13288_CR55","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/535613","volume":"2013","author":"S Azmin","year":"2013","unstructured":"Azmin S, Khairul Anuar AM, Nafisah WY, Tan HJ, Raymond AA, Hanita O, Shah SA, Norlinah MI (2013) Restless legs syndrome and its associated risk factors in Parkinson\u2019s disease. Parkinsons Dis 2013:535613. https:\/\/doi.org\/10.1155\/2013\/535613","journal-title":"Parkinsons Dis"},{"key":"13288_CR56","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1212\/01.wnl.0000078887.16593.12","volume":"61","author":"JR Connor","year":"2003","unstructured":"Connor JR, Boyer PJ, Menzies SL, Dellinger B, Allen RP, Ondo WG, Earley CJ (2003) Neuropathological examination suggests impaired brain iron acquisition in restless legs syndrome. Neurology 61:304\u2013309. https:\/\/doi.org\/10.1212\/01.wnl.0000078887.16593.12","journal-title":"Neurology"},{"key":"13288_CR57","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1093\/brain\/awp125","volume":"132","author":"JR Connor","year":"2009","unstructured":"Connor JR, Wang X-S, Allen RP, Beard JL, Wiesinger JA, Felt BT, Earley CJ (2009) Altered dopaminergic profile in the putamen and substantia nigra in restless leg syndrome. Brain 132:2403\u20132412. https:\/\/doi.org\/10.1093\/brain\/awp125","journal-title":"Brain"},{"key":"13288_CR58","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1016\/j.sleep.2014.05.009","volume":"15","author":"CJ Earley","year":"2014","unstructured":"Earley CJ, Connor J, Garcia-Borreguero D, Jenner P, Winkelman J, Zee PC, Allen R (2014) Altered brain iron homeostasis and dopaminergic function in restless legs syndrome (willis-ekbom disease). Sleep Med 15:1288\u20131301. https:\/\/doi.org\/10.1016\/j.sleep.2014.05.009","journal-title":"Sleep Med"},{"key":"13288_CR59","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1093\/sleep\/34.3.341","volume":"34","author":"CJ Earley","year":"2011","unstructured":"Earley CJ, Kuwabara H, Wong DF, Gamaldo C, Salas R, Brasic J, Ravert HT, Dannals RF, Allen RP (2011) The dopamine transporter is decreased in the striatum of subjects with restless legs syndrome. Sleep 34:341\u2013347. https:\/\/doi.org\/10.1093\/sleep\/34.3.341","journal-title":"Sleep"},{"key":"13288_CR60","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1097\/NRL.0b013e318183fdd8","volume":"15","author":"AC Felicio","year":"2009","unstructured":"Felicio AC, Shih MC, Godeiro-Junior C, Andrade LAF, Bressan RA, Ferraz HB (2009) Molecular imaging studies in Parkinson disease: reducing diagnostic uncertainty. Neurologist 15:6\u201316. https:\/\/doi.org\/10.1097\/NRL.0b013e318183fdd8","journal-title":"Neurologist"},{"key":"13288_CR61","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1111\/j.1471-4159.2008.05358.x","volume":"106","author":"LE Bianco","year":"2008","unstructured":"Bianco LE, Wiesinger J, Earley CJ, Jones BC, Beard JL (2008) Iron deficiency alters dopamine uptake and response to L-DOPA injection in sprague-dawley rats. J Neurochem 106:205\u2013215. https:\/\/doi.org\/10.1111\/j.1471-4159.2008.05358.x","journal-title":"J Neurochem"},{"key":"13288_CR62","doi-asserted-by":"publisher","first-page":"2831","DOI":"10.1093\/jn\/130.11.2831","volume":"130","author":"KM Erikson","year":"2000","unstructured":"Erikson KM, Jones BC, Beard JL (2000) Iron deficiency alters dopamine transporter functioning in rat striatum. J Nutr 130:2831\u20132837. https:\/\/doi.org\/10.1093\/jn\/130.11.2831","journal-title":"J Nutr"},{"issue":"Pt 12","key":"13288_CR63","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1093\/brain\/123.12.2423","volume":"123","author":"JM Graham","year":"2000","unstructured":"Graham JM, Paley MN, Gr\u00fcnewald RA, Hoggard N, Griffiths PD (2000) Brain iron deposition in Parkinson\u2019s disease imaged using the PRIME magnetic resonance sequence. Brain 123(Pt 12):2423\u20132431. https:\/\/doi.org\/10.1093\/brain\/123.12.2423","journal-title":"Brain"},{"key":"13288_CR64","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-14721-1","volume":"7","author":"Z Liu","year":"2017","unstructured":"Liu Z, Shen H-C, Lian T-H, Mao L, Tang S-X, Sun L, Huang X-Y, Guo P, Cao C-J, Yu S-Y, Zuo L-J, Wang X-M, Chen S-D, Chan P, Zhang W (2017) Iron deposition in substantia nigra: abnormal iron metabolism, neuroinflammatory mechanism and clinical relevance. Sci Rep 7:14973. https:\/\/doi.org\/10.1038\/s41598-017-14721-1","journal-title":"Sci Rep"},{"key":"13288_CR65","doi-asserted-by":"publisher","first-page":"7049108","DOI":"10.1155\/2016\/7049108","volume":"2016","author":"Y Mu\u00f1oz","year":"2016","unstructured":"Mu\u00f1oz Y, Carrasco CM, Campos JD, Aguirre P, N\u00fa\u00f1ez MT (2016) Parkinson\u2019s disease: the mitochondria-iron link. Parkinson\u2019s Dis 2016:7049108. https:\/\/doi.org\/10.1155\/2016\/7049108","journal-title":"Parkinson\u2019s Dis"},{"key":"13288_CR66","doi-asserted-by":"publisher","first-page":"10547","DOI":"10.1038\/s41598-017-10593-7","volume":"7","author":"Y-S Piao","year":"2017","unstructured":"Piao Y-S, Lian T-H, Hu Y, Zuo L-J, Guo P, Yu S-Y, Liu L, Jin Z, Zhao H, Li L-X, Yu Q-J, Wang R-D, Chen S-D, Chan P, Wang X-M, Zhang W (2017) Restless legs syndrome in Parkinson disease: Clinical characteristics, abnormal iron metabolism and altered neurotransmitters. Sci Rep 7:10547. https:\/\/doi.org\/10.1038\/s41598-017-10593-7","journal-title":"Sci Rep"},{"key":"13288_CR67","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1212\/wnl.52.5.932","volume":"52","author":"N Turjanski","year":"1999","unstructured":"Turjanski N, Lees AJ, Brooks DJ (1999) Striatal dopaminergic function in restless legs syndrome: 18F-dopa and 11C-raclopride PET studies. Neurology 52:932\u2013937. https:\/\/doi.org\/10.1212\/wnl.52.5.932","journal-title":"Neurology"},{"key":"13288_CR68","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1007\/pl00007859","volume":"249","author":"M Michaud","year":"2002","unstructured":"Michaud M, Soucy J-P, Chabli A, Lavigne G, Montplaisir J (2002) SPECT imaging of striatal pre- and postsynaptic dopaminergic status in restless legs syndrome with periodic leg movements in sleep. J Neurol 249:164\u2013170. https:\/\/doi.org\/10.1007\/pl00007859","journal-title":"J Neurol"},{"key":"13288_CR69","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1002\/1531-8257(199911)14:6<1025::aid-mds1020>3.0.co;2-p","volume":"14","author":"C Dentresangle","year":"1999","unstructured":"Dentresangle C, Veyre L, Le Bars D, Pierre C, Lavenne F, Pollak P, Guerin J, Froment JC, Brousolle E (1999) Striatal D2 dopamine receptor status in Parkinson\u2019s disease: an [18F]dopa and [11C]raclopride PET study. Mov Disord 14:1025\u20131030. https:\/\/doi.org\/10.1002\/1531-8257(199911)14:6%3c1025::aid-mds1020%3e3.0.co;2-p","journal-title":"Mov Disord"},{"key":"13288_CR70","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1002\/mds.870120107","volume":"12","author":"A Antonini","year":"1997","unstructured":"Antonini A, Schwarz J, Oertel WH, Pogarell O, Leenders KL (1997) Long-term changes of striatal dopamine D2 receptors in patients with Parkinson\u2019s disease: a study with positron emission tomography and [11C]raclopride. Mov Disord 12:33\u201338. https:\/\/doi.org\/10.1002\/mds.870120107","journal-title":"Mov Disord"},{"key":"13288_CR71","doi-asserted-by":"publisher","DOI":"10.1186\/2047-9158-1-6","volume":"1","author":"T Peeraully","year":"2012","unstructured":"Peeraully T, Tan E-K (2012) Linking restless legs syndrome with Parkinson\u2019s disease: clinical, imaging and genetic evidence. Transl Neurodegener 1:6. https:\/\/doi.org\/10.1186\/2047-9158-1-6","journal-title":"Transl Neurodegener"},{"key":"13288_CR72","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1212\/01.wnl.0000223316.53428.c9","volume":"67","author":"S Clemens","year":"2006","unstructured":"Clemens S, Rye D, Hochman S (2006) Restless legs syndrome: revisiting the dopamine hypothesis from the spinal cord perspective. Neurology 67:125\u2013130. https:\/\/doi.org\/10.1212\/01.wnl.0000223316.53428.c9","journal-title":"Neurology"},{"key":"13288_CR73","doi-asserted-by":"publisher","first-page":"925","DOI":"10.4103\/1673-5374.250567","volume":"14","author":"M Puopolo","year":"2019","unstructured":"Puopolo M (2019) The hypothalamic-spinal dopaminergic system: a target for pain modulation. Neural Regen Res 14:925\u2013930. https:\/\/doi.org\/10.4103\/1673-5374.250567","journal-title":"Neural Regen Res"},{"key":"13288_CR74","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/s0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H, Del Tredici K, R\u00fcb U, de Vos RAI, Jansen Steur ENH, Braak E (2003) Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol Aging 24:197\u2013211. https:\/\/doi.org\/10.1016\/s0197-4580(02)00065-9","journal-title":"Neurobiol Aging"},{"key":"13288_CR75","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1212\/wnl.54.7.1482","volume":"54","author":"V Kaasinen","year":"2000","unstructured":"Kaasinen V, N\u00e5gren K, Hietala J, Oikonen V, Vilkman H, Farde L, Halldin C, Rinne JO (2000) Extrastriatal dopamine D2 and D3 receptors in early and advanced Parkinson\u2019s disease. Neurology 54:1482\u20131487. https:\/\/doi.org\/10.1212\/wnl.54.7.1482","journal-title":"Neurology"},{"key":"13288_CR76","doi-asserted-by":"publisher","first-page":"204","DOI":"10.14802\/jmd.20160","volume":"14","author":"S Calzetti","year":"2021","unstructured":"Calzetti S, Negrotti A, Pietrini V (2021) Does restless legs syndrome have a different pathomechanism in premotor and motor Parkinson\u2019s disease? J Mov Disord 14:204\u2013207. https:\/\/doi.org\/10.14802\/jmd.20160","journal-title":"J Mov Disord"},{"key":"13288_CR77","doi-asserted-by":"publisher","first-page":"174480691988227","DOI":"10.1177\/1744806919882272","volume":"15","author":"Z Li","year":"2019","unstructured":"Li Z, Chen J, Lin Y, Zhou M, Cai Q, Li X, Wu Z, Chen X, Yang X, Zhu X, Lu J, Zhang L, Liu B, Luo X, Xu P (2019) Reduced regional activity and functional connectivity within sensorimotor network in Parkinson\u2019s patients with restless legs syndrome. Mol Pain 15:1744806919882272. https:\/\/doi.org\/10.1177\/1744806919882272","journal-title":"Mol Pain"},{"key":"13288_CR78","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1007\/s40120-022-00397-x","volume":"11","author":"QL Zang","year":"2022","unstructured":"Zang QL, Zheng JH, Ma JJ, Zhang Q, Huang PP, Shen NN, Miao W (2022) Neuroanatomy and functional connectivity in patients with Parkinson\u2019s disease with or without restless legs syndrome. Neurol Ther 11:1625\u20131636. https:\/\/doi.org\/10.1007\/s40120-022-00397-x","journal-title":"Neurol Ther"},{"key":"13288_CR79","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1080\/01616412.2016.1147682","volume":"38","author":"AQ Rana","year":"2016","unstructured":"Rana AQ, Mosabbir AA, Qureshi ARM, Abbas M, Rana MA (2016) Restless leg syndrome: a risk factor of higher prevalence of anxiety and depression in Parkinson\u2019s disease patients. Neurol Res 38:309\u2013312. https:\/\/doi.org\/10.1080\/01616412.2016.1147682","journal-title":"Neurol Res"},{"key":"13288_CR80","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.parkreldis.2020.09.015","volume":"81","author":"X-Y Zhu","year":"2020","unstructured":"Zhu X-Y, Wang H-M, Wu T-T, Liu T, Chen Y-J, Li X, Chen T-J, Liu Y, Zhang X-J, Wang X-X, Zhang Y, Ondo WG, Wu Y-C (2020) SNCA-rep1 polymorphism correlates with susceptibility and iron deficiency in restless legs syndrome. Parkinsonism Relat Disord 81:12\u201317. https:\/\/doi.org\/10.1016\/j.parkreldis.2020.09.015","journal-title":"Parkinsonism Relat Disord"},{"key":"13288_CR81","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jns.2018.08.028","volume":"394","author":"H Iwaki","year":"2018","unstructured":"Iwaki H, Hughes KC, Gao X, Schwarzschild MA, Ascherio A (2018) The association between restless legs syndrome and premotor symptoms of Parkinson\u2019s disease. J Neurol Sci 394:41\u201344. https:\/\/doi.org\/10.1016\/j.jns.2018.08.028","journal-title":"J Neurol Sci"},{"key":"13288_CR82","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1177\/1073858421991066","volume":"28","author":"T Wang","year":"2022","unstructured":"Wang T, Shi C, Luo H, Zheng H, Fan L, Tang M, Su Y, Yang J, Mao C, Xu Y (2022) Neuroinflammation in Parkinson\u2019s disease: triggers, mechanisms, and immunotherapies. Neuroscientist 28:364\u2013381. https:\/\/doi.org\/10.1177\/1073858421991066","journal-title":"Neuroscientist"},{"key":"13288_CR83","doi-asserted-by":"publisher","DOI":"10.1016\/j.smrv.2022.101744","volume":"68","author":"FJ Jim\u00e9nez-Jim\u00e9nez","year":"2023","unstructured":"Jim\u00e9nez-Jim\u00e9nez FJ, Alonso-Navarro H, Garc\u00eda-Mart\u00edn E, Ag\u00fandez JAG (2023) Inflammatory factors and restless legs syndrome: a systematic review and meta-analysis. Sleep Med Rev 68:101744. https:\/\/doi.org\/10.1016\/j.smrv.2022.101744","journal-title":"Sleep Med Rev"},{"key":"13288_CR84","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, Obeso J, Marek K, Litvan I, Lang AE, Halliday G, Goetz CG, Gasser T, Dubois B, Chan P, Bloem BR, Adler CH, Deuschl G (2015) MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov Disord 30:1591\u20131601. https:\/\/doi.org\/10.1002\/mds.26424","journal-title":"Mov Disord"},{"key":"13288_CR85","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2017.00171","author":"S Guo","year":"2017","unstructured":"Guo S, Huang J, Jiang H, Han C, Li J, Xu X, Zhang G, Lin Z, Xiong N, Wang T (2017) Restless legs syndrome: From pathophysiology to clinical diagnosis and management. Front Aging Neurosci. https:\/\/doi.org\/10.3389\/fnagi.2017.00171","journal-title":"Front Aging Neurosci"},{"key":"13288_CR86","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.sleep.2014.03.025","volume":"15","author":"RP Allen","year":"2014","unstructured":"Allen RP, Picchietti DL, Garcia-Borreguero D, Ondo WG, Walters AS, Winkelman JW, Zucconi M, Ferri R, Trenkwalder C, Lee HB, International Restless Legs Syndrome Study Group (2014) Restless legs syndrome\/willis-ekbom disease diagnostic criteria: Updated international restless legs syndrome study group (IRLSSG) consensus criteria-history, rationale, description, and significance. Sleep Med 15:860\u2013873. https:\/\/doi.org\/10.1016\/j.sleep.2014.03.025","journal-title":"Sleep Med"},{"key":"13288_CR87","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.3297","volume":"10","author":"V Kwatra","year":"2018","unstructured":"Kwatra V, Khan MA, Quadri SA, Cook TS (2018) Differential diagnosis and treatment of restless legs syndrome: a literature review. Cureus 10:e3297. https:\/\/doi.org\/10.7759\/cureus.3297","journal-title":"Cureus"},{"key":"13288_CR88","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1002\/mds.20969","volume":"21","author":"K Stiasny-Kolster","year":"2006","unstructured":"Stiasny-Kolster K, Kohnen R, M\u00f6ller JC, Trenkwalder C, Oertel WH (2006) Validation of the \u201cL-DOPA test\u201d for diagnosis of restless legs syndrome. Mov Disord 21:1333\u20131339. https:\/\/doi.org\/10.1002\/mds.20969","journal-title":"Mov Disord"},{"key":"13288_CR89","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.jns.2009.08.035","volume":"289","author":"JC M\u00f6ller","year":"2010","unstructured":"M\u00f6ller JC, Unger M, Stiasny-Kolster K, Oertel WH (2010) Restless legs syndrome (RLS) and parkinson\u2019s disease (PD)-related disorders or different entities? J Neurol Sci 289:135\u2013137. https:\/\/doi.org\/10.1016\/j.jns.2009.08.035","journal-title":"J Neurol Sci"},{"key":"13288_CR90","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1002\/mds.870090507","volume":"9","author":"CL Comella","year":"1994","unstructured":"Comella CL, Goetz CG (1994) Akathisia in Parkinson\u2019s disease. Mov Disord 9:545\u2013549. https:\/\/doi.org\/10.1002\/mds.870090507","journal-title":"Mov Disord"},{"key":"13288_CR91","doi-asserted-by":"publisher","first-page":"S12","DOI":"10.1212\/wnl.63.8_suppl_3.s12","volume":"63","author":"W Poewe","year":"2004","unstructured":"Poewe W, H\u00f6gl B (2004) Akathisia, restless legs and periodic limb movements in sleep in Parkinson\u2019s disease. Neurology 63:S12-16. https:\/\/doi.org\/10.1212\/wnl.63.8_suppl_3.s12","journal-title":"Neurology"},{"key":"13288_CR92","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/s41386-019-0448-y","volume":"45","author":"A Stefani","year":"2020","unstructured":"Stefani A, H\u00f6gl B (2020) Sleep in Parkinson\u2019s disease. Neuropsychopharmacology 45:121\u2013128. https:\/\/doi.org\/10.1038\/s41386-019-0448-y","journal-title":"Neuropsychopharmacology"},{"key":"13288_CR93","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1002\/mdc3.12088","volume":"1","author":"AS Walters","year":"2014","unstructured":"Walters AS, Frauscher B, Allen R, Benes H, Chaudhuri KR, Garcia-Borreguero D, Lee HB, Picchietti DL, Trenkwalder C, Martinez-Martin P, Schrag A, Stebbins G (2014) Review of severity rating scales for restless legs syndrome: critique and recommendations. Mov Disord Clin Pract 1:317\u2013324. https:\/\/doi.org\/10.1002\/mdc3.12088","journal-title":"Mov Disord Clin Pract"},{"key":"13288_CR94","doi-asserted-by":"publisher","unstructured":"Chinese Society of Neurology, Chinese Medical Doctor Association, Chinese Society of Sleep Disorders, Chinese Society of Sleep Disorders Professional Committee (2021) Chinese guidelines for the diagnosis and treatment of restless legs syndrome (2021 edition). Chin J Med 101:908\u2013925. https:\/\/doi.org\/10.3760\/cma.j.cn112137-20200820-02431(in Chinese)","DOI":"10.3760\/cma.j.cn112137-20200820-02431"},{"key":"13288_CR95","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1590\/0004-282X-anp-2020-0122","volume":"79","author":"MA Sobreira-Neto","year":"2021","unstructured":"Sobreira-Neto MA, Pena-Pereira MA, Sobreira EST, Chagas MHN, de Almeida CMO, Fernandes RMF, Tumas V, Eckeli AL (2021) Is restless legs syndrome in Parkinson disease patients associated with any specific factor? Arq Neuropsiquiatr 79:38\u201343. https:\/\/doi.org\/10.1590\/0004-282X-anp-2020-0122","journal-title":"Arq Neuropsiquiatr"},{"key":"13288_CR96","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/s1389-9457(02)00258-7","volume":"4","author":"AS Walters","year":"2003","unstructured":"Walters AS, LeBrocq C, Dhar A, Hening W, Rosen R, Allen RP, Trenkwalder C, International Restless Legs Syndrome Study Group (2003) Validation of the international restless legs syndrome study group rating scale for restless legs syndrome. Sleep Med 4:121\u2013132. https:\/\/doi.org\/10.1016\/s1389-9457(02)00258-7","journal-title":"Sleep Med"},{"key":"13288_CR97","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/s1389-9457(00)00080-0","volume":"2","author":"RP Allen","year":"2001","unstructured":"Allen RP, Earley CJ (2001) Validation of the Johns Hopkins restless legs severity scale. Sleep Med 2:239\u2013242. https:\/\/doi.org\/10.1016\/s1389-9457(00)00080-0","journal-title":"Sleep Med"},{"key":"13288_CR98","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.sleep.2015.10.014","volume":"20","author":"R Kohnen","year":"2016","unstructured":"Kohnen R, Martinez-Martin P, Benes H, Trenkwalder C, H\u00f6gl B, Dunkl E, Walters AS (2016) Rating of daytime and nighttime symptoms in RLS: validation of the RLS-6 scale of restless legs syndrome\/willis-ekbom disease. Sleep Med 20:116\u2013122. https:\/\/doi.org\/10.1016\/j.sleep.2015.10.014","journal-title":"Sleep Med"},{"key":"13288_CR99","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/j.sleep.2010.03.016","volume":"11","author":"R Arbuckle","year":"2010","unstructured":"Arbuckle R, Abetz L, Durmer JS, Ivanenko A, Owens JA, Croenlein J, Bolton K, Moore A, Allen RP, Walters AS, Picchietti DL (2010) Development of the pediatric restless legs syndrome severity scale (P-RLS-SS): a patient-reported outcome measure of pediatric RLS symptoms and impact. Sleep Med 11:897\u2013906. https:\/\/doi.org\/10.1016\/j.sleep.2010.03.016","journal-title":"Sleep Med"},{"key":"13288_CR100","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1097\/01.ajp.0000210948.11805.69","volume":"23","author":"AJ Bentley","year":"2007","unstructured":"Bentley AJ, Rosman KD, Mitchell D (2007) Can the sensory symptoms of restless legs syndrome be assessed using a qualitative pain questionnaire? Clin J Pain 23:62\u201366. https:\/\/doi.org\/10.1097\/01.ajp.0000210948.11805.69","journal-title":"Clin J Pain"},{"key":"13288_CR101","doi-asserted-by":"publisher","first-page":"1","DOI":"10.16306\/j.1008-861x.2021.03.001","volume":"35","author":"WT Li","year":"2021","unstructured":"Li WT, Gan J, Liu ZG (2021) Expert consensus on integrated traditional Chinese and western medicine management of sleep disorders in Parkinson\u2019s disease. J Shanghai Univ Tradit Chin Med 35:1\u20136. https:\/\/doi.org\/10.16306\/j.1008-861x.2021.03.001. (in Chinese)","journal-title":"J Shanghai Univ Tradit Chin Med"},{"key":"13288_CR102","doi-asserted-by":"publisher","first-page":"520","DOI":"10.7861\/clinmedicine.14-5-520","volume":"14","author":"L Klingelhoefer","year":"2014","unstructured":"Klingelhoefer L, Cova I, Gupta S, Chaudhuri KR (2014) A review of current treatment strategies for restless legs syndrome (Willis-Ekbom disease). Clin Med (Lond) 14:520\u2013524. https:\/\/doi.org\/10.7861\/clinmedicine.14-5-520","journal-title":"Clin Med (Lond)"},{"key":"13288_CR103","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.sleep.2011.03.003","volume":"12","author":"RP Allen","year":"2011","unstructured":"Allen RP, Ondo WG, Ball E, Calloway MO, Manjunath R, Higbie RL, Lee MR, Nisbet PA (2011) Restless legs syndrome (RLS) augmentation associated with dopamine agonist and levodopa usage in a community sample. Sleep Med 12:431\u2013439. https:\/\/doi.org\/10.1016\/j.sleep.2011.03.003","journal-title":"Sleep Med"},{"key":"13288_CR104","first-page":"13","volume":"6","author":"R Hoque","year":"2010","unstructured":"Hoque R (2010) Pharmacologically induced\/exacerbated restless legs syndrome, periodic limb movements of sleep, and REM behavior disorder\/REM sleep without atonia: literature review, qualitative scoring, and comparative analysis. J Clin Sleep Medicine JCSM 6:13\u201314","journal-title":"J Clin Sleep Medicine JCSM"},{"key":"13288_CR105","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1002\/mds.27260","volume":"33","author":"J Winkelmann","year":"2018","unstructured":"Winkelmann J, Allen RP, H\u00f6gl B, Inoue Y, Oertel W, Salminen AV, Winkelman JW, Trenkwalder C, Sampaio C (2018) Treatment of restless legs syndrome: evidence-based review and implications for clinical practice (revised 2017)\u00a7. Mov Disord 33:1077\u20131091. https:\/\/doi.org\/10.1002\/mds.27260","journal-title":"Mov Disord"},{"key":"13288_CR106","doi-asserted-by":"publisher","first-page":"2585","DOI":"10.1212\/WNL.0000000000003388","volume":"87","author":"JW Winkelman","year":"2016","unstructured":"Winkelman JW, Armstrong MJ, Allen RP, Chaudhuri KR, Ondo W, Trenkwalder C, Zee PC, Gronseth GS, Gloss D, Zesiewicz T (2016) Practice guideline summary: Treatment of restless legs syndrome in adults: report of the guideline development, dissemination, and implementation subcommittee of the American academy of neurology. Neurology 87:2585\u20132593. https:\/\/doi.org\/10.1212\/WNL.0000000000003388","journal-title":"Neurology"},{"key":"13288_CR107","doi-asserted-by":"publisher","first-page":"635","DOI":"10.5665\/sleep.3558","volume":"37","author":"D Garcia-Borreguero","year":"2014","unstructured":"Garcia-Borreguero D, Patrick J, DuBrava S, Becker PM, Lankford A, Chen C, Miceli J, Knapp L, Allen RP (2014) Pregabalin versus pramipexole: effects on sleep disturbance in restless legs syndrome. Sleep 37:635\u2013643. https:\/\/doi.org\/10.5665\/sleep.3558","journal-title":"Sleep"},{"key":"13288_CR108","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/s1389-9457(03)00010-8","volume":"4","author":"RP Allen","year":"2003","unstructured":"Allen RP, Picchietti D, Hening WA, Trenkwalder C, Walters AS, Montplaisi J, Restless Legs Syndrome Diagnosis and Epidemiology workshop at the National Institutes of Health, International Restless Legs Syndrome Study Group (2003) Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the national institutes of health. Sleep Med 4:101\u2013119. https:\/\/doi.org\/10.1016\/s1389-9457(03)00010-8","journal-title":"Sleep Med"},{"key":"13288_CR109","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1016\/S1474-4422(18)30311-9","volume":"17","author":"C Trenkwalder","year":"2018","unstructured":"Trenkwalder C, Allen R, H\u00f6gl B, Clemens S, Patton S, Schormair B, Winkelmann J (2018) Comorbidities, treatment, and pathophysiology in restless legs syndrome. Lancet Neurol 17:994\u20131005. https:\/\/doi.org\/10.1016\/S1474-4422(18)30311-9","journal-title":"Lancet Neurol"},{"key":"13288_CR110","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1111\/ene.13449","volume":"24","author":"IH Iftikhar","year":"2017","unstructured":"Iftikhar IH, Alghothani L, Trotti LM (2017) Gabapentin enacarbil, pregabalin and rotigotine are equally effective in restless legs syndrome: a comparative meta-analysis. Eur J Neurol 24:1446\u20131456. https:\/\/doi.org\/10.1111\/ene.13449","journal-title":"Eur J Neurol"},{"key":"13288_CR111","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s11940-019-0596-8","volume":"21","author":"V Cochen De Cock","year":"2019","unstructured":"Cochen De Cock V (2019) Therapies for restless legs in Parkinson\u2019s disease. Curr Treat Options Neurol 21:56. https:\/\/doi.org\/10.1007\/s11940-019-0596-8","journal-title":"Curr Treat Options Neurol"},{"key":"13288_CR112","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1002\/mds.23441","volume":"26","author":"C Trenkwalder","year":"2011","unstructured":"Trenkwalder C, Kies B, Rudzinska M, Fine J, Nikl J, Honczarenko K, Dioszeghy P, Hill D, Anderson T, Myllyla V, Kassubek J, Steiger M, Zucconi M, Tolosa E, Poewe W, Surmann E, Whitesides J, Boroojerdi B, Chaudhuri KR (2011) Rotigotine effects on early morning motor function and sleep in Parkinson\u2019s disease: a double-blind, randomized, placebo-controlled study (RECOVER). Mov Disord 26:90\u201399. https:\/\/doi.org\/10.1002\/mds.23441","journal-title":"Mov Disord"},{"key":"13288_CR113","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s11325-016-1414-0","volume":"21","author":"Y Wang","year":"2017","unstructured":"Wang Y, Yang Y-C, Lan D-M, Wu H-J, Zhao Z-X (2017) An observational clinical and video-polysomnographic study of the effects of rotigotine in sleep disorder in Parkinson\u2019s disease. Sleep Breath 21:319\u2013325. https:\/\/doi.org\/10.1007\/s11325-016-1414-0","journal-title":"Sleep Breath"},{"key":"13288_CR114","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/475630","volume":"2015","author":"F Vallderiola","year":"2015","unstructured":"Vallderiola F, Compta Y, Aparicio J, Tarradellas J, Salazar G, Oliver JM, Call\u00e9n A, Delgado T, Nobbe F (2015) Effects of night-time use of rotigotine on nocturnal symptoms in Parkinson\u2019s disease. Parkinsons Dis 2015:475630. https:\/\/doi.org\/10.1155\/2015\/475630","journal-title":"Parkinsons Dis"},{"key":"13288_CR115","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-015-0267-7","volume":"15","author":"J-M Kim","year":"2015","unstructured":"Kim J-M, Chung SJ, Kim JW, Jeon BS, Singh P, Thierfelder S, Ikeda J, Bauer L, Asia Pacific Rotigotine Add-on Study Group (2015) Rotigotine transdermal system as add-on to oral dopamine agonist in advanced Parkinson\u2019s disease: an open-label study. BMC Neurol 15:17. https:\/\/doi.org\/10.1186\/s12883-015-0267-7","journal-title":"BMC Neurol"},{"key":"13288_CR116","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/131508","volume":"2015","author":"J Pagonabarraga","year":"2015","unstructured":"Pagonabarraga J, Pi\u00f1ol G, Cardozo A, Sanz P, Puente V, Oterm\u00edn P, Legarda I, Delgado T, Serrano C, Balaguer E, Aguirregomozcorta M, \u00c1lvarez R, Kulisevsky JJ (2015) Transdermal rotigotine improves sleep fragmentation in Parkinson\u2019s disease: results of the multicenter, prospective SLEEP-FRAM study. Parkinsons Dis 2015:131508. https:\/\/doi.org\/10.1155\/2015\/131508","journal-title":"Parkinsons Dis"},{"key":"13288_CR117","doi-asserted-by":"publisher","first-page":"63","DOI":"10.2147\/DNND.S37268","volume":"5","author":"T Kesayan","year":"2015","unstructured":"Kesayan T, Shaw JD, Jones TM, Staffetti JS, Zesiewicz TA (2015) Critical appraisal of rotigotine transdermal system in management of Parkinson\u2019s disease and restless legs syndrome\u2014patient considerations. Degener Neurol Neuromuscul Dis 5:63\u201372. https:\/\/doi.org\/10.2147\/DNND.S37268","journal-title":"Degener Neurol Neuromuscul Dis"},{"key":"13288_CR118","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.sleep.2010.12.007","volume":"12","author":"B H\u00f6gl","year":"2011","unstructured":"H\u00f6gl B, Garcia-Borreguero D, Trenkwalder C, Ferini-Strambi L, Hening W, Poewe W, Brenner SS, Fraessdorf M, Busse M, Albrecht S, Allen RP (2011) Efficacy and augmentation during 6 months of double-blind pramipexole for restless legs syndrome. Sleep Med 12:351\u2013360. https:\/\/doi.org\/10.1016\/j.sleep.2010.12.007","journal-title":"Sleep Med"},{"key":"13288_CR119","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.1021\/acschemneuro.0c00332","volume":"11","author":"SM Wilson","year":"2020","unstructured":"Wilson SM, Wurst MG, Whatley MF, Daniels RN (2020) Classics in chemical neuroscience: pramipexole. ACS Chem Neurosci 11:2506\u20132512. https:\/\/doi.org\/10.1021\/acschemneuro.0c00332","journal-title":"ACS Chem Neurosci"},{"key":"13288_CR120","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.sleep.2013.05.016","volume":"14","author":"D Garcia-Borreguero","year":"2013","unstructured":"Garcia-Borreguero D, Kohnen R, Silber MH, Winkelman JW, Earley CJ, H\u00f6gl B, Manconi M, Montplaisir J, Inoue Y, Allen RP (2013) The long-term treatment of restless legs syndrome\/Willis-Ekbom disease: evidence-based guidelines and clinical consensus best practice guidance: a report from the international restless legs syndrome study group. Sleep Med 14:675\u2013684. https:\/\/doi.org\/10.1016\/j.sleep.2013.05.016","journal-title":"Sleep Med"},{"key":"13288_CR121","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1586\/14737175.5.1.35","volume":"5","author":"RS Kakar","year":"2005","unstructured":"Kakar RS, Kushida CA (2005) Ropinirole in the treatment of restless legs syndrome. Expert Rev Neurother 5:35\u201342. https:\/\/doi.org\/10.1586\/14737175.5.1.35","journal-title":"Expert Rev Neurother"},{"key":"13288_CR122","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.sleep.2017.11.1139","volume":"44","author":"J Kim","year":"2018","unstructured":"Kim J, Hartzema AG (2018) Adherence and persistence to ropinirole, pramipexole, and gabapentin in patients with newly diagnosed restless legs syndrome. Sleep Med 44:45\u201352. https:\/\/doi.org\/10.1016\/j.sleep.2017.11.1139","journal-title":"Sleep Med"},{"key":"13288_CR123","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1002\/mds.21050","volume":"21","author":"J Montplaisir","year":"2006","unstructured":"Montplaisir J, Karrasch J, Haan J, Volc D (2006) Ropinirole is effective in the long-term management of restless legs syndrome: a randomized controlled trial. Mov Disord 21:1627\u20131635. https:\/\/doi.org\/10.1002\/mds.21050","journal-title":"Mov Disord"},{"key":"13288_CR124","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1001\/jamainternmed.2014.5262","volume":"174","author":"TJ Moore","year":"2014","unstructured":"Moore TJ, Glenmullen J, Mattison DR (2014) Reports of pathological gambling, hypersexuality, and compulsive shopping associated with dopamine receptor agonist drugs. JAMA Intern Med 174:1930\u20131933. https:\/\/doi.org\/10.1001\/jamainternmed.2014.5262","journal-title":"JAMA Intern Med"},{"key":"13288_CR125","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.sleep.2016.01.017","volume":"21","author":"D Garcia-Borreguero","year":"2016","unstructured":"Garcia-Borreguero D, Silber MH, Winkelman JW, H\u00f6gl B, Bainbridge J, Buchfuhrer M, Hadjigeorgiou G, Inoue Y, Manconi M, Oertel W, Ondo W, Winkelmann J, Allen RP (2016) Guidelines for the first-line treatment of restless legs syndrome\/willis-ekbom disease, prevention and treatment of dopaminergic augmentation: a combined task force of the IRLSSG, EURLSSG, and the RLS-foundation. Sleep Med 21:1\u201311. https:\/\/doi.org\/10.1016\/j.sleep.2016.01.017","journal-title":"Sleep Med"},{"key":"13288_CR126","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1097\/WNF.0b013e3181a9eb1b","volume":"32","author":"S Perez Lloret","year":"2009","unstructured":"Perez Lloret S, Amaya M, Merello M (2009) Pregabalin-induced parkinsonism: a case report. Clin Neuropharmacol 32:353\u2013354. https:\/\/doi.org\/10.1097\/WNF.0b013e3181a9eb1b","journal-title":"Clin Neuropharmacol"},{"key":"13288_CR127","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.clineuro.2008.11.015","volume":"111","author":"C Erol","year":"2009","unstructured":"Erol C, Ozben S, Ozer F, Cetin S, Tiras R (2009) Bilateral ballism induced by gabapentin in idiopatic Parkinson\u2019s disease. Clin Neurol Neurosurg 111:397. https:\/\/doi.org\/10.1016\/j.clineuro.2008.11.015","journal-title":"Clin Neurol Neurosurg"},{"key":"13288_CR128","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1002\/mds.21209","volume":"22","author":"PM Raju","year":"2007","unstructured":"Raju PM, Walker RW, Lee MA (2007) Dyskinesia induced by gabapentin in idiopathic Parkinson\u2019s disease. Mov Disord 22:288\u2013289. https:\/\/doi.org\/10.1002\/mds.21209","journal-title":"Mov Disord"},{"key":"13288_CR129","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.3233\/JPD-212749","volume":"12","author":"L Sch\u00fctz","year":"2022","unstructured":"Sch\u00fctz L, Sixel-D\u00f6ring F, Hermann W (2022) Management of sleep disturbances in Parkinson\u2019s disease. J Parkinsons Dis 12:2029\u20132058. https:\/\/doi.org\/10.3233\/JPD-212749","journal-title":"J Parkinsons Dis"},{"key":"13288_CR130","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1016\/S1474-4422(13)70239-4","volume":"12","author":"C Trenkwalder","year":"2013","unstructured":"Trenkwalder C, Bene\u0161 H, Grote L, Garc\u00eda-Borreguero D, H\u00f6gl B, Hopp M, Bosse B, Oksche A, Reimer K, Winkelmann J, Allen RP, Kohnen R, RELOXYN Study Group (2013) Prolonged release oxycodone-naloxone for treatment of severe restless legs syndrome after failure of previous treatment: a double-blind, randomised, placebo-controlled trial with an open-label extension. Lancet Neurol 12:1141\u20131150. https:\/\/doi.org\/10.1016\/S1474-4422(13)70239-4","journal-title":"Lancet Neurol"},{"key":"13288_CR131","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1016\/S1474-4422(15)00243-4","volume":"14","author":"C Trenkwalder","year":"2015","unstructured":"Trenkwalder C, Chaudhuri KR, Martinez-Martin P, Rascol O, Ehret R, Vali\u0161 M, S\u00e1tori M, Krygowska-Wajs A, Marti MJ, Reimer K, Oksche A, Lomax M, DeCesare J, Hopp M, PANDA study group (2015) Prolonged-release oxycodone-naloxone for treatment of severe pain in patients with Parkinson\u2019s disease (PANDA): a double-blind, randomised, placebo-controlled trial. Lancet Neurol 14:1161\u20131170. https:\/\/doi.org\/10.1016\/S1474-4422(15)00243-4","journal-title":"Lancet Neurol"},{"key":"13288_CR132","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2017.00042","volume":"8","author":"G Loddo","year":"2017","unstructured":"Loddo G, Calandra-Buonaura G, Sambati L, Giannini G, Cecere A, Cortelli P, Provini F (2017) The treatment of sleep disorders in Parkinson\u2019s disease: from research to clinical practice. Front Neurol 8:42. https:\/\/doi.org\/10.3389\/fneur.2017.00042","journal-title":"Front Neurol"},{"key":"13288_CR133","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-015-0331-3","volume":"15","author":"G Grolez","year":"2015","unstructured":"Grolez G, Moreau C, Sablonni\u00e8re B, Gar\u00e7on G, Devedjian J-C, Meguig S, Gel\u00e9 P, Delmaire C, Bordet R, Defebvre L, Cabantchik IZ, Devos D (2015) Ceruloplasmin activity and iron chelation treatment of patients with Parkinson\u2019s disease. BMC Neurol 15:74. https:\/\/doi.org\/10.1186\/s12883-015-0331-3","journal-title":"BMC Neurol"},{"key":"13288_CR134","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3233\/JPD-223284","volume":"13","author":"K Opova","year":"2023","unstructured":"Opova K, Limousin P, Akram H (2023) Spinal cord stimulation for gait disorders in Parkinson\u2019s disease. J Parkinsons Dis 13:57\u201370. https:\/\/doi.org\/10.3233\/JPD-223284","journal-title":"J Parkinsons Dis"},{"key":"13288_CR135","doi-asserted-by":"publisher","first-page":"S18","DOI":"10.1093\/pm\/pnad089","volume":"24","author":"GL Pagani-Est\u00e9vez","year":"2023","unstructured":"Pagani-Est\u00e9vez GL, Holland MT, Tippmann-Peikert M, Benarroch EE, Silber MH, Carvalho DZ (2023) Potential therapeutic benefit of spinal cord stimulation in restless legs syndrome: scoping review and mechanistic considerations. Pain Med 24:S18\u2013S23. https:\/\/doi.org\/10.1093\/pm\/pnad089","journal-title":"Pain Med"},{"key":"13288_CR136","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2022.101589","volume":"52","author":"W Zhang","year":"2022","unstructured":"Zhang W, Deng B, Xie F, Zhou H, Guo J-F, Jiang H, Sim A, Tang B, Wang Q (2022) Efficacy of repetitive transcranial magnetic stimulation in Parkinson\u2019s disease: a systematic review and meta-analysis of randomised controlled trials. EClinicalMedicine 52:101589. https:\/\/doi.org\/10.1016\/j.eclinm.2022.101589","journal-title":"EClinicalMedicine"},{"key":"13288_CR137","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.4103\/0366-6999.159344","volume":"128","author":"Y-C Lin","year":"2015","unstructured":"Lin Y-C, Feng Y, Zhan S-Q, Li N, Ding Y, Hou Y, Wang L, Lin H, Sun Y, Huang Z-Y, Xue Q, Wang Y-P (2015) Repetitive transcranial magnetic stimulation for the treatment of restless legs syndrome. Chin Med J (Engl) 128:1728\u20131731. https:\/\/doi.org\/10.4103\/0366-6999.159344","journal-title":"Chin Med J (Engl)"},{"key":"13288_CR138","doi-asserted-by":"publisher","first-page":"e1013","DOI":"10.1212\/WNL.0000000000006162","volume":"91","author":"O Klepitskaya","year":"2018","unstructured":"Klepitskaya O, Liu Y, Sharma S, Sillau SH, Tsai J, Walters AS (2018) Deep brain stimulation improves restless legs syndrome in patients with Parkinson disease. Neurology 91:e1013\u2013e1021. https:\/\/doi.org\/10.1212\/WNL.0000000000006162","journal-title":"Neurology"},{"key":"13288_CR139","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1002\/mds.20911","volume":"21","author":"E Driver-Dunckley","year":"2006","unstructured":"Driver-Dunckley E, Evidente VGH, Adler CH, Hillman R, Hernandez J, Fletcher G, Lyons MK (2006) Restless legs syndrome in Parkinson\u2019s disease patients may improve with subthalamic stimulation. Mov Disord 21:1287\u20131289. https:\/\/doi.org\/10.1002\/mds.20911","journal-title":"Mov Disord"},{"key":"13288_CR140","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.parkreldis.2010.11.017","volume":"17","author":"LM Chahine","year":"2011","unstructured":"Chahine LM, Ahmed A, Sun Z (2011) Effects of STN DBS for Parkinson\u2019s disease on restless legs syndrome and other sleep-related measures. Parkinsonism Relat Disord 17:208\u2013211. https:\/\/doi.org\/10.1016\/j.parkreldis.2010.11.017","journal-title":"Parkinsonism Relat Disord"},{"key":"13288_CR141","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.sleep.2024.02.025","volume":"115","author":"L Tordjman","year":"2024","unstructured":"Tordjman L, Lagha-Boukbiza O, Anheim M, Tranchant C, Bourgin P, Ruppert E (2024) Restless legs syndrome in the dominant Parkinson\u2019s side related to subthalamic deep-brain stimulation. Sleep Med 115:174\u2013176. https:\/\/doi.org\/10.1016\/j.sleep.2024.02.025","journal-title":"Sleep Med"},{"key":"13288_CR142","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.sleep.2014.11.020","volume":"16","author":"A Marques","year":"2015","unstructured":"Marques A, Fantini ML, Morand D, Pereira B, Derost P, Ulla M, Debilly B, Lemaire J-J, Durif F (2015) Emergence of restless legs syndrome after subthalamic stimulation in Parkinson\u2019s disease: a dopaminergic overstimulation? Sleep Med 16:583\u2013588. https:\/\/doi.org\/10.1016\/j.sleep.2014.11.020","journal-title":"Sleep Med"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-025-13288-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-025-13288-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-025-13288-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T10:35:28Z","timestamp":1760524528000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-025-13288-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,11]]},"references-count":142,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["13288"],"URL":"https:\/\/doi.org\/10.1007\/s00415-025-13288-6","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,11]]},"assertion":[{"value":"30 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"On behalf of all authors, the corresponding author states that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}],"article-number":"567"}}